| USD millions | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | TTM | Trend | YoY |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Cost of revenue | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.0 | — | |
| Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | (1.0) | — | |
| Research & development | 0.0 | 0.0 | 56.3 | 73.1 | 121.2 | 162.2 | +33.8% | |
| Selling, general & administrative | 0.0 | 0.0 | 8.5 | 7.8 | 24.6 | — | — | |
| Selling & marketing | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Operating expenses | 0.0 | 0.0 | 64.8 | 80.9 | 145.8 | 198.8 | +36.3% | |
| Operating income | (0.0) | (0.0) | (64.8) | (80.9) | (145.8) | (199.0) | −36.4% | |
| Interest expense | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Interest income | 0.0 | 0.0 | 0.1 | 8.5 | 11.3 | 15.4 | +35.4% | |
| Other income / expense | 0.0 | 0.0 | 0.1 | 8.2 | 11.8 | — | — | |
| Pre-tax income | (0.0) | (0.0) | (64.7) | (74.3) | (134.0) | (182.1) | −35.9% | |
| Income tax | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | |
| Net income | (0.0) | (0.0) | (64.7) | (74.3) | (134.0) | (182.1) | −35.9% | |
| Discontinued operations | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| Other net income adjustments | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | — | — | |
| EPS, basic (per share) | (0.00) | 0.00 | (3.16) | 0.46 | (4.30) | (708.07) | −16366.7% | |
| EPS, diluted (per share) | (0.00) | (0.00) | (3.16) | 0.46 | (4.30) | (708.07) | −16366.7% | |
| EBITDA | (0.0) | (0.0) | (64.7) | (80.7) | (145.2) | (198.5) | −36.7% | |
| Depreciation & amortization | 0.1 | 0.0 | 0.1 | 0.2 | 0.6 | 0.4 | −27.4% | |
| Weighted average shares (shares) | 20,485,000 | 20,485,000 | 20,485,000 | 16,636,000 | 31,144,775 | — | — | |
| Weighted average diluted shares (shares) | 20,485,000 | 20,485,000 | 20,485,000 | 16,636,000 | 31,144,775 | — | — |
Amounts are shown in the stated units; per-share amounts and shares are unscaled. Negative amounts are in brackets.
TTM ends 2026-06-30 and uses four consecutive reported quarters.
